STOCK TITAN

Former major Rezolute (RZLT) holder Invus group now reports 0% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Invus Public Equities and related investment entities report that they no longer beneficially own any shares of Rezolute, Inc. common stock, representing 0% of the class as of December 31, 2025. Each reporting person lists 0 shares for voting and dispositive power, confirming ownership has fallen below the 5% reporting threshold. The filing formally amends prior Schedule 13G disclosures and includes a certification that the securities were not acquired or held for the purpose of changing or influencing control of Rezolute.

Positive

  • None.

Negative

  • None.

Insights

A prior large holder now reports 0% ownership in Rezolute.

The filing shows Invus Public Equities and affiliated entities, including Avicenna Life Sci Master Fund and related LLCs, now report beneficial ownership of 0 Rezolute common shares, or 0% of the class, as of December 31, 2025.

This Schedule 13G/A indicates their position has been fully exited or otherwise reduced below reporting thresholds, and they certify that the securities were not acquired or held to influence control. Actual market impact depends on when and how any dispositions occurred, which is not detailed here.

Subsequent company disclosures and ownership filings may provide additional context on Rezolute’s evolving shareholder base and any new holders crossing the 5% threshold after December 31, 2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Invus Public Equities, L.P.
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Date:02/13/2026
Invus Public Equities Advisors, LLC
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:02/13/2026
Invus Global Management, LLC
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:02/13/2026
Siren, L.L.C.
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:02/13/2026
Avicenna Life Sci Master Fund LP
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Date:02/13/2026
Avicenna Life Sci Master GP LLC
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, Chief Executive Officer
Date:02/13/2026
Ulys, L.L.C.
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:02/13/2026
Raymond Debbane
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane
Date:02/13/2026

FAQ

What change in ownership does the Rezolute (RZLT) Schedule 13G/A report?

The Schedule 13G/A reports that Invus Public Equities and affiliated entities now beneficially own 0 Rezolute common shares, or 0% of the class, as of December 31, 2025. This amends prior disclosures where they held at least 5% of the company’s stock.

Who are the reporting persons in the Rezolute (RZLT) Schedule 13G/A?

The reporting persons are Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Invus Global Management, LLC, Siren, L.L.C., Avicenna Life Sci Master Fund LP, Avicenna Life Sci Master GP LLC, Ulys, L.L.C., and Raymond Debbane. They are collectively referred to as the Reporting Persons.

What percentage of Rezolute (RZLT) does each reporting person now own?

Each reporting person reports beneficial ownership of 0 Rezolute common shares, representing 0% of the outstanding common stock. Their sole and shared voting and dispositive powers are all listed as 0, confirming no remaining reportable economic or voting interest in the issuer.

What class of Rezolute (RZLT) securities is covered in this Schedule 13G/A?

The filing covers Rezolute’s common stock, with a par value of $0.001 per share, identified by CUSIP 76200L309. It confirms that, for this class of securities, the Reporting Persons no longer hold any beneficial ownership as of December 31, 2025.

What certification do the reporting persons make in the Rezolute (RZLT) 13G/A?

The reporting persons certify that the securities referenced were not acquired and are not held for the purpose of changing or influencing control of Rezolute. They also state the holdings were not part of any transaction intended to affect control, aside from activities tied to a nomination under Rule 14a-11.

What does ‘Ownership of 5 percent or less’ mean in the Rezolute (RZLT) filing?

The filing’s ‘Ownership of 5 percent or less of a class’ item confirms the Reporting Persons’ aggregate ownership has dropped below the 5% threshold. Because they now report 0% ownership, they no longer qualify as significant beneficial owners under Section 13(d) reporting rules.
Rezolute Inc

NASDAQ:RZLT

RZLT Rankings

RZLT Latest News

RZLT Latest SEC Filings

RZLT Stock Data

336.60M
82.85M
9.68%
90.03%
8.53%
Biotechnology
Pharmaceutical Preparations
Link
United States
REDWOOD CITY